Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)

LAKE FOREST, Ill.--(BUSINESS WIRE)-- #acutekidneyinjury--Nephraegis Therapeutics announces their launch with a seed investment from Xontogeny to advance their lead compound through critical preclinical work

Click to view original post